Dr. Ekkehard Brockstedt

TCM Biosimilars

Back to Speakers

Ekkehard Brockstedt is a clinical research professional with more than 15 years of experience in drug development from phase II-IV with a focus on biologics. He has led the conduct of global clinical trial programmes as well as global PASS Phase IV programmes in multiple therapeutic areas such as immunology/inflammatory diseases (Rheumatoid Arthritis, Morbus Crohn, Ulcerative Colitis, Psoriasis), oncology (Multiple Myeloma), and cardio-metabolic diseases (Stroke, DVT).
Prior to joining Boehringer Ingelheim he has held various project leader positions in clinical research and R&D project management at PRA Health Sciences Inc., Sankyo Pharma GmbH as well as Schering AG.
Ekkehard holds a Diplom Chemiker degree from the Freie Universität, Berlin, a PhD in protein biochemistry from the Technische Universität, Berlin (MDC-Berlin) and an MBA from the University of Edinburgh.